Experimental and clinical trials of long acting oxytetracycline in the treatment of canine ehrlichiosis

Vet Q. 1985 Apr;7(2):158-61. doi: 10.1080/01652176.1985.9693974.

Abstract

Four splenectomized dogs were experimentally infected with Ehrlichia canis and treated at the point of illness with long acting (LA) Oxytetracycline at different dosages. Terramycin LA, when given at a dose of 20 mg/kg body weight (deep intramuscularly) twice, at a four-day interval, was found to have effectively controlled the disease and has replaced the usual 7-14 successive days' treatment regimen when other groups of tetracycline drugs are used. Predef 2X at the rate of 2 mg given intramuscularly concurrently eliminated the local inflammatory reaction caused by the injection of Terramycin LA. Twenty-four out of the 26 naturally infected dogs which were treated in a similar way were completely cured; one died before it could receive the full treatment, and another received a second medication five weeks after the first treatment, showing recurrent epistaxis; blood samples taken from this dog were negative for E. canis.

Publication types

  • Clinical Trial

MeSH terms

  • Animals
  • Clinical Trials as Topic / veterinary
  • Delayed-Action Preparations
  • Dog Diseases / drug therapy*
  • Dogs
  • Ehrlichia
  • Injections, Intramuscular / veterinary
  • Oxytetracycline / administration & dosage
  • Oxytetracycline / therapeutic use*
  • Rickettsiaceae Infections / drug therapy
  • Rickettsiaceae Infections / veterinary*

Substances

  • Delayed-Action Preparations
  • Oxytetracycline